Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
SPDR S&P Biotech ETF
Similar ETFs
Trading data
XBI performance and flow charts
Performance
Flows
Historic performance and flows
Data as of March 10, 2026| 1M | 3M | YTD | 1Y | 3Y | 5Y | |
|---|---|---|---|---|---|---|
| Perf. | +1.75% | +4.75% | +4.50% | +48.40% | +69.29% | -9.32% |
| Flows | -$21M | -$262M | -$163M | -$25M | -$1.83B | +$1.19B |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Volatility | +25.66% | +28.03% | +27.31% | +32.96% |
Max drawdown | -8.19% | -21.44% | -32.94% | -57.63% |
Max drawdown duration | 47d | 141d | 331d | 1821d |
Time to recover | N/A | 127d | 183d | N/A |
Replication quality
Data as of February 27, 2026Create an account to view replication metrics
1 year cumulative return difference | |
|---|---|
| Best | Join for free |
| Worst | Join for free |
| daily return difference | |
|---|---|
| Average | Join for free |
| Worst | Join for free |
Exposure
Data as of January 31, 2026Countries
Sectors
Diversification
Total weight of top 15 holdings out of 149
Top 15 Holdings
Characteristics
The SPDR S&P Biotech ETF is built to track the S&P Biotechnology Select Industry Total Return Index - USD. This ETF provides physical exposure - by owning its shares you earn the return of the securities composing the index (as the ETF holds them directly).
This share class generates a stream of income by distributing dividends.
| Management strategy | Passive |
| Provider | SPDR |
| N° of holdings | 149 |
| Replication method | Direct (Physical) |
| Asset class | Equities |
| Dividend policy | Distributing |
Trailing 12m distribution yield | Join for free |
| Inception date | January 31, 2006 |
| ESG | No |
Latest news about XBI
What type of ETF is XBI?
XBI is a Passive ETF that provides exposure to Equity assets. It is managed by SPDR.
What index does XBI track?
XBI tracks the S&P Biotechnology Select Industry Total Return Index - USD, aiming to replicate its performance through full replication.
What does XBI invest in?
This ETF provides exposure to Equally Weighted US Biotechnology Equities. It is part of the segment: US Health Care.
What is the expense ratio of XBI?
The total expense ratio (TER) of XBI is 0.35%, representing the annual fee charged by the fund manager.
When was XBI launched?
XBI was launched on January 31, 2006, marking its entry into the ETF market.
Who is the issuer of XBI?
XBI is issued by SPDR.
What is the AUM of XBI?
As of March 10, 2026, XBI manages $8.06 B, reflecting the total assets held in the fund.
How has XBI performed recently?
As of March 10, 2026, XBI delivered a return of 1.75% over the past month (1M performance), 4.75% over the past three months (3M), and 4.5% year-to-date (YTD).
What are the recent fund flows for XBI?
As of March 10, 2026, XBI has seen net flows of -$21M in the past month (1M flow) and -$163M year-to-date (YTD).
Does XBI pay dividends?
As of March 10, 2026, XBI has a trailing 12-month distribution yield of 0.35%.
How many holdings are in XBI
As of January 31, 2026, XBI holds 149 securities in its portfolio. This level of diversification can influence the fund’s risk profile and exposure to individual assets.
How diversified is XBI?
As of January 31, 2026, XBI holds 149 securities, with 21.6% of its assets concentrated in its top 15 holdings.
What are the top holdings of XBI?
As of January 31, 2026, XBI holds a portfolio of 149 underlyings, with its largest positions including MODERNA INC, MIRUM PHARMACEUTICALS INC and REVOLUTION MEDICINES INC. These top holdings play a significant role in shaping the fund’s performance and exposure.
What countries or regions does XBI invest in?
As of January 31, 2026, XBI has its largest geographic exposures in USA.
What sectors or themes does XBI focus on?
As of January 31, 2026, XBI is primarily exposed to Health Care.
Advantages of ETFs over Mutual Funds1/6
Lower Costs
In this guide, we'll explore the advantages of ETFs over mutual funds, giving you valuable insights into why ETFs have gained significant popularity among investors like yourself.
Leveraged ETFs: Unlocking the Potential for Amplified Returns1/6
Understanding Leveraged ETFs
Explore leveraged ETFs: potential for amplified returns & risks. 5 ETFs to consider across equities, commodities & fixed income.
What is a Leveraged ETF?1/6
Introducing Leveraged and Inverse ETFs
In this guide, we'll dive into the world of leveraged ETFs, exploring their definition, mechanics, potential risks, and rewards.
Recent educational content
Asset TV
The ETF Show - US-Iran Conflict Sends Oil ETFs Soaring
Lance McGray, Managing Director and Head of ETF Product at Advisors Asset Management joins The ETF Show.
What’sTheFund
What's the Fund | Thrivent Small Cap Value ETF (Ticker: TSCV)
Kyle Detullio, ETF Capital Markets Specialist at Thrivent Asset Management, joins Ethan Hertzfeld on the NYSE trading floor to discuss the Thrivent Small Cap Value ETF (TSCV).
What’sTheFund
What's the Fund | Thrivent Small-Mid Cap Equity ETF (Ticker: TSME)
Kyle Detullio, ETF Capital Markets Specialist at Thrivent Asset Management, joins Ethan Hertzfeld on the NYSE trading floor to discuss the Thrivent Small-Mid Cap Equity ETF (TSME).
What’sTheFund
What's the Fund | Thrivent Mid Cap Value ETF (Ticker: TMVE)
Kyle Detullio, ETF Capital Markets Specialist at Thrivent Asset Management, joins Ethan Hertzfeld on the NYSE trading floor to discuss the Thrivent Mid Cap Value ETF (TMVE).
Browse all educational columns
Calamos Investments Powers the Next Phase of the Autocallable Revolution
Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.
Accepted for 1 CE Credit
